Trials / Recruiting
RecruitingNCT06126016
A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
A Multi-center, Prospective, Non-interventional, Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.(Paricalcitol) for Secondary Hyperparathyroidism With Stage 5D Chronic Kidney Disease (CKD 5D) Receiving Hemodialysis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of pacitol Inj.(paricalcitol) for secondary hyperparathyroidism with stage 5D chronic kidney disease (CKD 5D) receiving hemodialysis
Conditions
Timeline
- Start date
- 2023-10-19
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2023-11-13
- Last updated
- 2024-12-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06126016. Inclusion in this directory is not an endorsement.